Testing a new DBS programming method for Parkinson's
Part of Brain & nervous system clinical trials.
This study tests a new way to program deep brain stimulation (DBS) using brain signals, which may improve symptom control. It is for people with Parkinson's who have a Medtronic Percept DBS device and are ready for their first programming session.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with idiopathic Parkinson's disease using standard criteria
- Already have a Medtronic Percept DBS device implanted
- Able to understand and sign the consent form
- Willing to take part during your first DBS programming session
- Between the ages of 21 and 89
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your own ratings of your Parkinson's symptoms can help fine-tune your deep brain stimulation (DBS) settings. It is for people with Parkinson's who already have a DBS device that can record brain activity.
This study uses brain signals (called local field potentials) from the deep brain stimulation (DBS) device to see if they can predict how well the treatment is working. It aims to help doctors adjust DBS settings more precisely for people with Parkinson's disease.
This study tests a new way of using deep brain stimulation (like a pacemaker for the brain) to help control Parkinson's symptoms. It may help improve movement and quality of life for people living with Parkinson's disease.
This study compares two ways of adjusting the settings for deep brain stimulation (a treatment for Parkinson's disease). One way uses standard clinical methods; the other uses special biological markers to guide the settings. The goal is to find which method works better for controlling symptoms.
This study tests whether different deep brain stimulation settings can improve symptoms in people with Parkinson’s who already have an implanted DBS system in the subthalamic nucleus (STN). To join, you must already have the specific Medtronic device and show good brain signal and symptom response after surgery.
This study is for people with Parkinson's disease who already have a deep brain stimulator (a device that sends electrical pulses to the brain) and still have motor fluctuations (times when symptoms come and go). The researchers want to see if adapting the device's settings can better control symptoms than the current standard settings.
Hear when a new Parkinson's Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.